Skip to Main Content

Paper Details

Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.
Front Immunol
1
2023
Author NameAffiliation
Bart L HaagmansErasmus Medical Center
  • 1 - 1

Datasets

Release 1.2